Cardiopediatric Home Monitoring Tool
ConditionCongenital Heart Defect
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-36
SponsorNantes University Hospital
About this trial
We hypothesize that a home monitoring program combined with routine postoperative care significantly reduces morbidity and mortality after neonatal and pediatric cardiac surgery. This project differs from the previously published experiences by (a) providing an innovative telemedicine solution via the use of validated measurement sensors, (b) an alert system based on individualized standards, established for each care pathway, and (c) a protocolized response from medical teams in the management of alerts generated by the home monitoring tool.
Eligibility criteria
Qualifiers
Patients aged between 0 and 36 months inclusive
With a congenital heart defect
Underwent cardiac surgery at Nantes University Hospital
Affiliated to a social security scheme
Disqualifiers
None
Trial design
Treatments tested in this trial
- Home monitoring
- usual medical monitoring
Treatment groups
186 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov